Programs and Activities

Hepatology School

With the diagnosis and treatment of liver disease undergoing dramatic change, new therapies have created the need for comprehensive educational opportunities. Initiated as Hepatitis School, the new Hepatology School encompasses treatment of frequently diagnosed liver disease states. The ACG’s Hepatology School is designed to better enable clinical gastroenterologists and primary care physicians to triage, treat, and refer patients more efficiently.

IBD School

IBD School was fi rst introduced in 2017 and is modelled after the highly successfully Hepatology Schoo—a day-long educational program that combines an immersion in IBD management with a clinical update on new therapeutic and monitoring approaches. The goals of this course are to improve clinical judgment and to address the art and science of IBD management.

Functional GI Disorders School

Functional GI diseases are among the most commonly diagnosed in the United States. ACG’s Functional GI School addresses all aspects of treatment for a wide variety of conditions and seeks to empower attendees not only with new diagnostic knowledge, but also the ability to better communicate with their patients about diagnosis and treatment. Enrollment is open to all clinicians.

ACG Young Physician Leadership Scholars Program

The Young Physician Leadership Scholars Program is an intensive program that provides a focused cohort of young GI clinicians the opportunity to build foundational leadership and advocacy skill and to develop executive decision-making capabilities. Motivated young physicians are brought together to exchange ideas as they work to enhance critical thinking and comprehend organizational behavior. The program combines online learning, participation in legislative advocacy, and live course work at the ACG Annual Meeting.

Research Grants

Since the founding of the ACG Institute in 1994, funding has been provided to 640 investigators, totaling more than $21.3 million for research directly relating to the practice of clinical gastroenterology. Looking ahead, the ACG Institute’s continued investment in career development awards and funding for GI fellows-in-training will foster clinical innovations in gastroenterology and hepatology that will improve patient care and strengthen the capabilities of practitioners. The College is proud of the achievements of its funded investigators and plans to invest more fully in their leadership and success.

ACG Edgar Achkar Visiting Professorship Program

The goal of the ACG Edgar Achkar Visiting Professorship Program, which honors former ACG Institute Director, Edgar Achkar, MD, MACG, is to enable GI fellowship programs to have high-quality visiting professors to bolster the training program by providing lectures, small group discussions, and one-on-one visits with trainees and faculty. You choose the speaker, the Institute covers the travel costs and honorarium.

Pancreatitis Task Force on Quality

The incidence of acute pancreatitis is rising. It is the leading gastrointestinal cause of hospitalization in the United States with mortality ranging from 3% in patients with interstitial edematous pancreatitis, to 17% in patients who develop pancreatic necrosis. To address the urgent need to provide improved patient care, the Acute Pancreatitis Task Force on Quality developed validated pancreatitis care management quality indicators which hospitals and clinicians may use to assess their performance and develop initiatives that improve patient care and outcomes.

Evidence-Based Monographs and Reviews

IBS Monograph

The Functional Bowel Disease Task Force was convened by the ACG Institute to review the meta-analysis of new RCT research and evaluate the analysis utilizing the GRADE system of evaluation. This criterion, which is a best practice means of evaluating data, was used in creating the updated recommendations for 2018.

IBD Monograph

The College and the ACG Institute published a new evidence-based systematic review on the management of Inflammatory Bowel Disease as a supplement to The American Journal of Gastroenterology (AJG) for April 2011. This clinical monograph, based on a comprehensive meta-analysis, offers new graded recommendations on medical management of IBD.